Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/03/2012WO2012057336A1 Hair growth agent composition
05/03/2012WO2012057312A1 Tau imaging probe
05/03/2012WO2012057300A1 Novel pyridine derivative
05/03/2012WO2012057294A1 Method for treating malaria, method for killing malaria parasite, and use of the methods
05/03/2012WO2012057291A1 Process for production of phenolic polymerizable compound having physiological activity
05/03/2012WO2012057288A1 Novel anti-dr5 antibody
05/03/2012WO2012057262A1 Pyridine derivative and medicinal agent
05/03/2012WO2012057248A1 Naphthyridine derivative
05/03/2012WO2012057247A1 Fused aminodihydropyrimidine derivative
05/03/2012WO2012057220A1 Percutaneously absorbed preparation
05/03/2012WO2012057212A1 Percutaneous absorption type formulation
05/03/2012WO2012057103A1 Pharmaceutical composition
05/03/2012WO2012057068A1 23-yne-vitamin d3 derivative
05/03/2012WO2012056976A1 Modulator of activity of adenylate cyclase
05/03/2012WO2012056509A1 Pharmaceutical composition
05/03/2012WO2012056478A1 Oxazole and isoxazole crac modulators
05/03/2012WO2012056468A1 A process for the preparation of bosentan
05/03/2012WO2012056465A1 A process for preparing curcumin encapsulated chitosan alginate sponge useful for wound healing
05/03/2012WO2012056452A2 Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
05/03/2012WO2012056442A1 Polymorphs of febuxostat
05/03/2012WO2012056402A2 Formulations and methods for attenuating respiratory depression induced by opioid overdose
05/03/2012WO2012056387A2 A dermaceutical gel made using sodium fusidate and a process to make it
05/03/2012WO2012056372A1 N1/N2-LACTAM ACETYL-CoA CARBOXYLASE INHIBITORS
05/03/2012WO2012056344A1 Use of a spironolactone-based composition that exhibits an inhibitory action on t-lympocyte activation which is useful for preventing and/or treating multiple sclerosis
05/03/2012WO2012056299A1 Nasal compositions of vitamin b12
05/03/2012WO2012056251A1 Inflammatory disease
05/03/2012WO2012056246A1 Combination treatment of major depressive disorder
05/03/2012WO2012056229A1 Inflammatory disease
05/03/2012WO2012056205A1 Peptide
05/03/2012WO2012056120A1 Use of a modulator of the patched protein for regulating intracellular cholesterol concentration
05/03/2012WO2012056113A1 Composition and method for influencing energy metabolism and treating metabolic and other disorders
05/03/2012WO2012056048A1 Treatment of inflammation
05/03/2012WO2012056044A1 Treatment for dupuytren's disease
05/03/2012WO2012055995A1 Tricyclic compounds as mpges-1 inhibitors
05/03/2012WO2012055987A1 Novel drug target site within gp120 of hiv
05/03/2012WO2012055953A1 Substituted phenoxypyridines
05/03/2012WO2012055952A1 Crystalline form of 13-[(n-tert-butoxycarbonyl)-2'-o-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin iii
05/03/2012WO2012055945A1 Indole derivatives and process for their preparation
05/03/2012WO2012055944A1 Oral pharmaceutical film formulation for bitter-tasting drugs
05/03/2012WO2012055942A1 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease
05/03/2012WO2012055941A1 Multilayer pharmaceutical composition comprising telmisartan and amlodipine
05/03/2012WO2012055894A1 Diterpenoid derivatives endowed of biological properties
05/03/2012WO2012055888A1 Diaza-spiro[5.5]undecanes useful as orexin receptor antagonists
05/03/2012WO2012055884A1 Dosing regimes for the treatment of ocular vascular disease
05/03/2012WO2012055880A1 Method of treatment based on atad2 inhibitors
05/03/2012WO2012055879A1 Method of treatment by inhibition of baz1b
05/03/2012WO2012055846A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5- { [4-(1-methylethyl)-1-pi perazinyl] methyl} -1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders
05/03/2012WO2012055844A1 Semuloparin for use as an antithrombotic treatment in major abdominal surgery with improved safety in terms of clinically relevant bleedings and major bleedings
05/03/2012WO2012055843A1 Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdominal surgery
05/03/2012WO2012055840A1 Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders
05/03/2012WO2012055826A1 TREATMENT OF MeCP2-ASSOCIATED DISORDERS
05/03/2012WO2012055814A1 Compound inducing lbpa accumulation for inhibiting cell-to-cell transmission of hiv
05/03/2012WO2012055708A1 Medicinal product comprising hydromorphone, with improved shelf-life
05/03/2012WO2012055573A1 Use of hepcidin binding nucleic acids for depletion of hepcidin from the body
05/03/2012WO2012055571A1 Ophthalmic composition
05/03/2012WO2012055568A1 Liposomal drug composition containing a polymeric guanidine derivative
05/03/2012WO2012055567A2 Use of malononitrilamides in neuropathic pain
05/03/2012WO2012055466A1 Quinazoline derivatives
05/03/2012WO2012055369A1 Quinazoline derivative and quinazoline complex protein kinase inhibitor for inhibiting multiplication of tumor cells and preparation method thereof
05/03/2012WO2012055346A1 Polymorph of n-(6-(4-chlorophenoxy)hexyl)-n'-cyano-n''-(4-pyridyl)guanidine, and preparation therefor and use thereof
05/03/2012WO2012055169A1 C-arylglucoside derivative, preparation method therefor, and use thereof
05/03/2012WO2012055163A1 Letrozole type i crystal and preparation method thereof
05/03/2012WO2012055090A1 Drink for supplementing energy and recovering from fatigue, prepaing method and utility thereof
05/03/2012WO2012055066A1 Acarbose composition with effect of lowering blood glucose and preparation method thereof
05/03/2012WO2012055057A1 Therapeutic use of dimiracetam to prevent the hand & foot syndrome caused by sorafenib
05/03/2012WO2012055034A1 Sulfonamides as hiv protease inhibitors
05/03/2012WO2012055031A1 Hiv protease inhibitors
05/03/2012WO2012055020A1 Thermosensitive liposomes
05/03/2012WO2012055018A1 Therapeutic compositions for diabetic symmetrical polyneuropathy
05/03/2012WO2012055015A1 Combination comprising an atp analog and an adenosine receptor antagonist or a nucleobase/nucleoside analog for the treatment of cancer
05/03/2012WO2012055014A1 Phenylketone carboxylate compounds and pharmaceutical uses thereof
05/03/2012WO2012055010A1 Maple tree-derived products and uses thereof
05/03/2012WO2012054996A1 Functionalized aryl and/or heteroaryl urea compounds; a method for synthesizing same; a pharmaceutical composition containing such compounds and uses thereof
05/03/2012WO2012054988A1 Seleno-compounds and therapeutic uses thereof
05/03/2012WO2012054978A1 Novel anti-cancer agents
05/03/2012WO2012032523A9 Compositions comprising acidic extracts of mastic gum
05/03/2012WO2012032417A3 Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin
05/03/2012WO2012032415A3 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
05/03/2012WO2012032414A3 Compositions comprising a fatty acid oil mixture, a surfactant, and a statin
05/03/2012WO2012027558A3 OPTIMIZED miRNA CONSTRUCTS
05/03/2012WO2012025762A3 Pure intermediate for preparing letrozole
05/03/2012WO2012020966A3 Theanine derivative, preparation method thereof, and use thereof for alleviating acne
05/03/2012WO2012020097A3 Use of binders for manufacturing storage stable formulations
05/03/2012WO2012019015A3 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
05/03/2012WO2012018980A3 Compositions and methods for treating inflammatory diseases
05/03/2012WO2012018235A3 Method for preparing decitabine with improved yield and purity
05/03/2012WO2012011673A3 Pharmaceutical composition including hesperetin as an active ingredient for promoting muscle cell differentiation or renewal
05/03/2012WO2012009611A9 Methods and compositions for cancer immunotherapy
05/03/2012WO2012008697A3 Orally administered agent for increasing sperm count
05/03/2012WO2012006525A3 Pkc activators and anticoagulant in regimen for treating stroke
05/03/2012WO2012005500A3 Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration
05/03/2012WO2012003461A3 Phloroglucinol synthases and methods of making and using the same
05/03/2012WO2012003145A3 Therapeutic agents for ocular hypertension
05/03/2012WO2011162560A3 Pharmaceutical composition in which solubility of partially soluble tricyclic derivative is improved
05/03/2012WO2011162515A3 Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
05/03/2012WO2011162480A3 Composition for treating prion diseases comprising hif-1α agonist
05/03/2012WO2011159137A3 Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating aids, containing same as active ingredient
05/03/2012WO2011159124A3 Novel benzoxazole derivative having inhibitory activity against interleukin-6, preparation method thereof, and pharmaceutical composition containing same
05/03/2012WO2011159100A3 Anti-cancer pharmaceutical composition
05/03/2012WO2011155797A3 Hemioxalate salt of crystalline o-desmethylvenlafaxine, preparation method thereof, and pharmaceutical composition thereof
1 ... 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 ... 7860